Bridging the Gap: Index Volume [International Conference on AIDS (12th: 1998: Geneva, Switzerland)]

12th World AIDS Conference

Empowering * Enterocytozoon 57

Keyword Abstract -
nteragency HIV Study/ stories of women and HIV: T 44264
nteragency HIV study/ stories of women and HIV: T 44278
n education programs/ youth to confront HIV/AIDS i 60377
mmunity-wide impact of empowering women with HIV/Each one t 33556
rs program: Sustaining care and support as partners 34262
E (Tools for Health and Empowerment) Course on medication ad 14271
lity of life of all of them/ of patients HIV positive, fa 24268
S prevention activities/ of community based rural 34128
HE (Tools for Health and ) course: A unique disease 639*/34236
bout their human rights/ to the people living with HI 34272
ith HIV/AIDS (PWA)/ processes to improve the 43366
ong women in Malawi/ an effective strategy to the 60032
GA group processes/ of needy HIV infected wo 60157
tool - An issue for PHA empowerment /Developing appropriate q 12458
/"Posit(HIV)e Life"/Self- of people living with HIV/AI 24273
men/Evaluating a group model for HIV+ gay Puerto 24276
gh peer education and /Reducing risk taking beha 33529
ome care and women's /Community based home c 264*/34102
gh economic and social /Community response to H 34142
esigning and facilitating with organized PLWH/As: 34171
es/The partnership for:Redesigning a community 34237
grams = education and /Peer run programs = educ 34266
es/Peer education and is achievable via consultati 34282
HIV/AIDS and women's /Socio-economic burdens 42460
ces through literacy and /AIDS prevention practices 43350
land, USA/LUCES: An model for Latinos in Maryla 60865
health fraud task forces empowers communities to make informed 34376
STDs/Social economic commercial sex workers to red 43253
usative agent of pleural empyema in a patient with HIV infection/A 32263
sions about sexuality to enable behavior change among the youth i 14316
reatment education to HIV positive people to make effecti 32363
UK ASO programme to people living with HIV to explore th 34315
e preparedness study/ Enabling women to participate in HIV vacc 33215
ut HIV drug treatments/ an informed personal choice abo 42227
capacity building for of enabling environment, using networks an 34263
women/Creation of an and gender just legal environme 539*/44164
nd anti-HIV activity of enantiomeric oxaselenolane nucleosides 41200
f SCID mice with HIV-1 encephalitis /Abacavir (1592, ABC) preve 556*/11233
ain barrier during HIV-1 /Microglia secrete chemoattr 21138
PCP) and toxoplasmic (TE)/A randomized trial of co 22181
ings/Cytomegalovirus in eight patients with AIDS: C 22253
eated children with HIV encephalopathy /Efficacy of switching to c 12177
hocytes/DNA vaccine encoding an HIV epitope fused with HBV s 11240
ypox vectors (ALVAC) multiple HIV gene products (vC 495*/21192
of the HLA-A28 antigen alleles by sequence based typin 21202
reement for last sexual encounter among male homosexual coupl 14105
s/New sharing partners places among needle exchang 23187
est results/Challenges encountered and solutions adopted in cou 43115
afe and unsafe sexual encounters of bisexual men in Ontario, Ca 14179
aradox/Serodiscordant reveal a prevention paradox/ 14322
dom use in commercial /Taking care of business: Wo 43240
e course of new sexual: A general population study in 60733
couple HIV counselling encourage client disclosure of serostatus 593*/24323
ve media campaigns to compliance with anti-HIV treat 32394
ainst hepatitis B/How to youth to get vaccinated agains 33567
elf and community care/ Encouraging self shared confidentiality pr 33326
IV/AIDS in Mongolia/ a multisectoral response to 60110
for decision analysis in end-of-life decision making in HIV: AIDS-r 22436
th AIDS at risk for CMV end-organ disease/A comparison of four 22246
"The Road to Geneva"/ End of Life issues - "The Road to Geneva" 44*"/22438
s in HIV-1 infection until end stage disease/Increased turnover of b 268*/21108
nd confidentiality: An to AIDS "exceptionalism"?/HIV testin 43216
- the beginning from the /Calling in a culture - the beginning fro 43378
roconversion to clinical points/The Scottish National AIDS/HI 43419

Keyword Abstract --
valuation of the corneal endothelium in rabbits treated with sub-co 11237
c mechanism of action/ Energy balance studies during growth hor 32188
erminants of increased energy expenditure in HIV-infected wome 337*/32162
RNA/Increased resting expenditure (REE) is associated wi 32168
Mexico, Arbol de la Vida Enfermos en Superaci6n, I.A.P. Mexico Ci 34335
IV-positive men who engage in sex with men/Predictors of high 23122
other natural helpers to substance abusers in treatment/P 33604
njecting drug users in England and Wales, 1991-97: Possibilties 23199
k factors in prisoners in and Wales in 1997: Results of a n 23510
r African PWAs living in /Peer education and support for A 33543
en: Is it cost-effective in? Study for the EU Concerted Acti 43134
V prevention strategy in /Interventions in public sex venue 43271
ct targetting gay men in /CHAPS: Developing a nationally 43309
recent HIV incidence in and Wales/Combining sequentia 43440
exual/bisexual group in and Wales/A simulation model to 43469
tion on HIV/AIDS in the English speaking Caribbean/Analysis of t 13164
PWAs "going public" in enhacing HIV/AIDS awareness among sc 43361
/NSI and not SI viruses enhance cell proliferation and beta-chemo 21175
avioral group programs the process of adaptation to livin 24355
/Support intervention to medication adherence/Support i 32349
g "Stop Sida" kiosks to and strengthen the information e 33442
ntervention strategy to support mechanisms/Using doc 34230
V educational booklet to caregivers' knowledge of HIV/Uti 42242
testing technologies to HIV prevention: Evaluation of ora 43106
event HIV infection and reproductive health among adole 60993
in Macaca nemestrina/ Enhanced pathogenicity of SHIV HXBc2 f 11218
ected (EU) individuals/ production of monocyte-derive 31140
tures of AIDS patients/ of phagocytosis and germicidal 31187
of hydroxyurea in vitro/ activation of nucleoside analog 42262
emokine RANTES with enhanced HIV-suppressive and reduced p 11101
STDs: A mechanism for HIV-1 transmission?/Increased 13280
aqManT"-based product reverse transcriptase assay/Q 41137
HIV+ patients warrants nutrition education/Limited kno 42341
ed antibody-dependent enhancement of HIV infection correlates t 21132
ect of mycobacteria on of HIV replication is mainly 21145
h to self care/Wellness through creativity: Art thera 24314
rofound but incomplete of anti-HIV-1 CTLm respon 112*/31124
unity consortium: Does of physician knowledge of a 32307
Medication adherence after viral genotyping in HIV 32357
men using motivational and behavioral skills trainin 33274
al men: When optimism enhances risk/Antiretroviral drugs and se 14137
es/Triggering of CD30 HIV-1 replication in acutely infe 21153
s in mice/Nonoxynol-9 rectal infection by herpes simpl 33143
-NGO exchange visits/ Enhancing quality of AIDS programs throu 34352
rn and southern Africa/ training capacities through reg 359*/43391
tions capacity building/ sustainability for developing c 44263
or women/Motivational enhancing and skills building HIV risk redu 33272
vertising strategies for referrals of urban and rural ma 33494
n in PBMC/Methionine enkephalin: a new cytokine inhibits HIV re 60525
on (FNA)/Lymph node enlargement in HIV patients: Diagnosis by 60073
nd preventive methods/ Enlightenment of the existence of HIV/AI 33594
ia/Impact of HIV/AIDS enlightenment on acceptability of male co 23344
al/Impact of HIV/AIDS on acceptability of condom 60126
work Male Prostitution ( ENMP )/European Network Male Prostituti 60904
e deaf: A necessity and enrichment /An adapted access to health 32424
esults from 55 patients enrolled during primary infection in France 12187

cal outcome in patients
nfected (HIV+) women
e sex with men (MSM)
ections among women
HIV-) high-risk women
x with women (WSWs)
ncentrations in patients
n HIV-infected patients
IV-infected drug users
pies by PHA voluntarily
disease among women
er covariates in women

in the alpha ddl trial/Immunologic
in the Women's Interagency HIV
in a cohort study on HIV incidenc
in the Women's Interagency HIV
in the HIVNET vaccine preparedn
in a high-risk US cohort/HIV risk
in clinical trials/Cerebrospinal flui
in a phase III clinical trial/Populati
in opiate substitution programs at
in an observational database/Tre
in the Women's Interagency HIV
in the Women's Interagency HIV

IV/AIDS clinical trials
tease inhibitors and the

/Ethical vs. moral duties when HIV/AID 475*/44126
of consensus/AIDS, virtually normal n 637*/44183

patients/Palliative care/ of life and counselling in HIV/AIDS/can
ase 6 months after the of chemotherapy: First report/Prolong
and support in Senegal. Enda sante, Dakar, Senegal/A community
and support in Senegal: Sante, Dakar, Senegal/A communit
HIV patients living in an endemic region?/Coccidioidomycosis: An
oidy in epidemic (AKS), (EKS), and classical (CKS) Kapo
rcoma in an African KS area/Immune status of HIV-infec
/Increased IL-10 in the endocervix of women with STDs: A mech
/Amantidine and other endocytic pathway blockers inhibit HIV inf
plication/HIV-1 Vif is an endogenous inhibitor of HIV-1 protease a
xpression of the human retrovirus HERV-K/A Rev/R
atients/Gastrointestinal endoscopy in HIV-1 infected patients/Ga
ent prognosis markers/ Endothelial cell dysfunction in HIV infectio
man blood-brain barrier endothelial cell receptors by HIV/Modulat

60069
60510
13431
33312
22220
620*/22282
60970
13280
32212
377*/11130
11208
60949
12139
60794

of babies not infected at enrollment /HIV infection due to breastfee
~)/Improving patients' into clinical trials: The experien
I trial to improve patient and compliance/Lessons lear
-related treatment and in clinical trials for persons livin
viral (ICONA) study and data/Issues of Italian Cohort N
HIV-1 infected adults in Entebbe, Uganda/Falciparum malaria an
n in peri-urban areas of, Uganda/Promoting HIV/AIDS a
DS prevention adopting enter-education strategies/Youth mobiliz
minary investigation of enteric-coated pancrelipase therapy in HI
ort study/Diarrhea and enteric pathogens in HIV infected patients:
ations of mycobacterial infection in patients with AIDS/Clin
illin for the treatment of Enterocytozoon bieneusi infections in pati

12234
13309
14106
22191
23447
23500
32202
42267
42281
42390
60269
60299
457*/23270
42207
42208
44166
60929
130*/22236
60046
33559
60391
32102
32110
22232